3B Blackbio Dx Limited (NSE:3BBLACKBIO)

3B Blackbio Dx Statistics

Total Valuation

3B Blackbio Dx has a market cap or net worth of INR 10.96 billion. The enterprise value is 10.79 billion.

Market Cap	10.96B
Enterprise Value	10.79B

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	8.57M
Shares Outstanding	n/a
Shares Change (YoY)	+1.69%
Shares Change (QoQ)	-1.03%
Owned by Insiders (%)	47.56%
Owned by Institutions (%)	3.82%
Float	2.78M

Valuation Ratios

The trailing PE ratio is 19.07.

PE Ratio	19.07
Forward PE	n/a
PS Ratio	8.50
PB Ratio	3.61
P/TBV Ratio	3.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	18.78
EV / Sales	8.37
EV / EBITDA	19.23
EV / EBIT	19.61
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	n/a
Interest Coverage	311.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	15.19%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	15.17M
Profits Per Employee	6.76M
Employee Count	85
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, 3B Blackbio Dx has paid 167.02 million in taxes.

Income Tax	167.02M
Effective Tax Rate	22.31%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	7,867

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 3B Blackbio Dx had revenue of INR 1.29 billion and earned 574.68 million in profits. Earnings per share was 67.66.

Revenue	1.29B
Gross Profit	926.03M
Operating Income	550.30M
Pretax Income	748.62M
Net Income	574.68M
EBITDA	561.38M
EBIT	550.30M
Earnings Per Share (EPS)	67.66

Balance Sheet

The company has 227.67 million in cash and 2.62 million in debt, with a net cash position of 225.05 million.

Cash & Cash Equivalents	227.67M
Total Debt	2.62M
Net Cash	225.05M
Net Cash Per Share	n/a
Equity (Book Value)	3.04B
Book Value Per Share	355.75
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	11.08M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 71.80%, with operating and profit margins of 42.67% and 44.56%.

Gross Margin	71.80%
Operating Margin	42.67%
Pretax Margin	58.04%
Profit Margin	44.56%
EBITDA Margin	43.52%
EBIT Margin	42.67%
FCF Margin	n/a

Dividends & Yields

3B Blackbio Dx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.69%
Shareholder Yield	-1.69%
Earnings Yield	5.24%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1